Daniela Molena, Woo Jin Hyung, Zev A. Wainberg, Moishe Liberman, Gunnar Folprecht, Inmaculada Ales Diaz, Takaki Yoshikawa, Salah-Eddin Al-Batran, Eric Van Cutsem, Kei Muro, Peter Philipp Grimminger, Takeshi Omori, Miguel Sotelo Lezama, István Sipocz, Myriam Chalabi, Lin-Yang Cheng, Eric Heilbron, Scott Robbins, Yelena Y. Janjigian, Josep Tabernero. "Surgical journey for participants (pts) in the MATTERHORN trial: A global, randomized, phase 3 study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.353